Different pathways for deoxyguanosine toxicity in T-lymphocytes of various developmental stages
- 1 January 1988
- journal article
- research article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 10 (6) , 675-686
- https://doi.org/10.1016/0192-0561(88)90021-5
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Deoxyadenosine triphosphate as a mediator of deoxyguanosine toxicity in cultured T lymphoblasts.Journal of Clinical Investigation, 1986
- Regulation of thymocyte proliferation and survival by deoxynucleosides. Deoxycytidine produced by thymic accessory cells protects thymocytes from deoxyguanosine toxicity and stimulates their spontaneous proliferationEuropean Journal of Immunology, 1986
- Functional and mechanistic studies on the toxicity of deoxyguanosine for thein vitro proliferation and differentiation of human peripheral blood B lymphocytesEuropean Journal of Immunology, 1986
- 2'-deoxyguanosine toxicity for B and mature T lymphoid cell lines is mediated by guanine ribonucleotide accumulation.Journal of Clinical Investigation, 1984
- Lymphocyte Maturation in the Human Thymus.Scandinavian Journal of Immunology, 1983
- The role of purine metabolic enzymes and terminal deoxynucleotidyl transferase in intrathymic T-cell differentiationImmunology Today, 1983
- Expression of adenosine deaminase and purine nucleoside phosphorylase isozymes in lymphohemopoietic precursor cells and normal and neoplastic lymphoid populationsCellular Immunology, 1982
- Deoxyguanosine Triphosphate as a Possible Toxic Metabolite in the Immunodeficiency Associated with Purine Nucleoside Phosphorylase DeficiencyJournal of Clinical Investigation, 1978
- Purine Nucleoside Phosphorylase Deficiency Associated with Selective Cellular ImmunodeficiencyNew England Journal of Medicine, 1977
- ADENOSINE-DEAMINASE DEFICIENCY IN TWO PATIENTS WITH SEVERELY IMPAIRED CELLULAR IMMUNITYThe Lancet, 1972